|
|
|
Insider
Information: |
Sinha Uma |
Relationship: |
Director |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
46,460 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$681,341 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
46,460 |
|
|
Total
Value |
$681,341 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eidos Therapeutics, Inc. |
EIDX |
Chief Scientific Officer |
2021-01-26 |
0 |
|
0 |
Premium* |
|
Bridgebio Pharma, Inc. |
BBIO |
Chief Scientific Officer |
2020-11-16 |
16,460 |
2019-07-01 |
0 |
Premium* |
|
Prokidney Ord Shs Class A |
PROK |
Director |
2022-07-11 |
30,000 |
2022-07-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(303,525) |
0 |
0 |
- |
|
PROK |
Prokidney Ord Shs Class A |
Director |
|
2022-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Scientific Officer |
|
2019-07-01 |
4 |
B |
$17.00 |
$238,000 |
D/D |
14,000 |
14,000 |
2.74 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2019-12-18 |
4 |
S |
$61.61 |
$773,794 |
D/D |
(12,500) |
331,081 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-01-13 |
4 |
AS |
$121.11 |
$1,243,179 |
D/D |
(10,000) |
306,525 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2019-05-23 |
4 |
S |
$27.16 |
$136,376 |
D/D |
(5,000) |
349,312 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2019-07-25 |
4 |
S |
$35.65 |
$180,627 |
D/D |
(5,000) |
346,081 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-10-29 |
4 |
AS |
$71.90 |
$362,099 |
D/D |
(5,000) |
321,525 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-10-01 |
4 |
AS |
$52.35 |
$252,923 |
D/D |
(4,831) |
326,525 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-10-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
303,525 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2019-09-25 |
4 |
S |
$38.38 |
$96,016 |
D/D |
(2,500) |
343,581 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2019-05-31 |
4 |
A |
$12.01 |
$21,247 |
D/D |
1,769 |
351,081 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Scientific Officer |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,523 |
15,523 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2018-11-30 |
4 |
A |
$12.01 |
$12,983 |
D/D |
1,081 |
354,312 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Scientific Officer |
|
2020-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
469 |
16,460 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Scientific Officer |
|
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
468 |
15,991 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-05-31 |
4 |
A |
$41.57 |
$18,459 |
D/D |
444 |
331,525 |
0 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-09-30 |
4 |
AS |
$52.00 |
$8,794 |
D/D |
(169) |
331,356 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|